Skip to content

Ultrasound Guyded Venous Puncture for Safe AF Ablation Procedures

Ultrasound Guyded Venous Puncture for Safe AF Ablation Procedures

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06403527
Acronym
ULYSSES
Enrollment
1075
Registered
2024-05-08
Start date
2024-03-03
Completion date
2026-02-04
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Puncture for Safe Atrial Fibrillation Ablation

Brief summary

To assess if ultrasound guided venous puncture reduces the risk for access site complication in the contex of atrial fibrillation ablation.

Interventions

OTHERUltrasound guided venous access during AF ablation

Ultrasound guided venous access during AF ablation

Sponsors

Cardioangiologisches Centrum Bethanien
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Investigator-initiated, prospective, randomized, interventional, multicenter trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion Criteria 1. Age ≥18 years 2. Signed written informed consent 3. Planned transvenous catheter ablation procedure for AF or left atrial tachycardia 4. Willingness to participate in follow-up

Exclusion criteria

1. Patient is unable or unwilling to provide informed consent 2. Planned/required arterial access (e.g. for blood pressure monitoring) 3. Patient has contra-indication to oral anticoagulation 4. Known coagulation disorder or Thrombocytopenia \<150.000/ul. 6\. Women currently pregnant or breastfeeding or women of childbearing potential without highly effective contraception (PEARL-Index \< 1%), 7. Patient is included in another clinical trial 8. Inability to comply with the study procedures

Design outcomes

Primary

MeasureTime frameDescription
occurrence of venous access site complications30 daysoccurrence of venous access site complications until 30 days after the procedure defined as AV fistula, false aneurysm or access site bleeding requiring intervention (BARC 3 A or higher)

Countries

Germany

Contacts

STUDY_CHAIRNeda Tarighi, Doctor

CCB

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026